Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by Stocktreeon May 24, 2023 10:59am
182 Views
Post# 35461868

Not a "fudster", just not a pumper

Not a "fudster", just not a pumperYou think the role of a poster is to promote the stock. I think it is to discuss the pros and cons of an investment. And since you are always exagerating the potential of the stock on a volcanic scale, and without taking into consideration the history of the company, other posters need to balance your used needle salesman act.

In this case, it's easy.
10 patients over the last 132 days.
At this pace, the end of recruitment, not of trial, is August 2026.
Dead money until then.
And with app. 1 patient enrolled per site during a period of 4+ month period, the product is not showing promising to take over the sepsis market any time soon, so no revenues for a big while.
Also, where is the cash we were going to be buried in thanks to Dialco? Let's forget about that adventure altogether I guess.

And for longtime shareholders who are not pumping the stock this morning for day trading purposes, the stock is still at 32 cents, which is in the realm of what it has been for the past 20 years.
Volume today at 11:00 am: 0

<< Previous
Bullboard Posts
Next >>